Skip to content

Life Enhancer probiotics capsule improves clinical symptoms of patients with postcholecystectomy diarrhea: A single-center randomized controlled study

Life Enhancer probiotics capsule improves clinical symptoms of patients with postcholecystectomy diarrhea: A single-center randomized controlled study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082619
Enrollment
Unknown
Registered
2024-04-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postcholecystectomy diarrhea

Interventions

Experimental group:Take Life Enhancer probiotics capsules orally,Twice a day, One at a time
Control Group:Placebo

Sponsors

Shanghai Fourth People's Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) voluntary participation in the study, willing to sign the informed consent; (2) age 18 to 75 years old, gender is not limited; (3) previous cholecystectomy was performed in our hospital because of benign gallbladder disease without other surgery-related complications; The patients had no diarrhea before operation, and had recurrent diarrhea after operation, and the course of disease was =1 month; (4) no other intestinal microflora preparations were taken within 3 months of study entry.

Exclusion criteria

Exclusion criteria: (1) the patients who did not have benign disease of gallbladder only underwent cholecystectomy, such as liver cancer and cholecystectomy at the same time; (2) they had the history of gastrointestinal tract and pancreas operation; (3) colonoscopy can clearly detect organic lesions of the digestive system, such as ulcerative colitis, Crohn's disease and tumors of the digestive system; The patients were diagnosed as functional diseases of the digestive system, such as functional dyspepsia and irritable bowel syndrome (IBS) ; (4)with diarrhea before cholecystectomy or less than one month after cholecystectomy (5) having a severe primary disease or other life-threatening illness; (6) being allergic to a compound probiotic; (7) being pregnant, lactating or not ruling out pregnancy; (8) having participated in other drug trials within 3 months; (9) there are long-term use of yoghurt and other products habitually; (10) researchers do not think that participants.

Design outcomes

Primary

MeasureTime frame
Remission rate of diarrhea symptoms;

Secondary

MeasureTime frame
Remission rate of other concomitant symptoms of diarrhea;The change of Spectrum of intestinal flora;

Countries

China

Contacts

Public ContactZhenshun Song

Shanghai Fourth People's Hospital Affiliated to Tongji University

zhenshunsong@aliyun.com+86 189 1768 3278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026